These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37574616)

  • 1. Variations in metabolite profiles of serum coronas produced around PEGylated liposomal drugs by surface property.
    Jang GJ; Jeong JY; Joung H; Han SY
    Colloids Surf B Biointerfaces; 2023 Oct; 230():113488. PubMed ID: 37574616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-parametric surface plasmon resonance platform for studying liposome-serum interactions and protein corona formation.
    Kari OK; Rojalin T; Salmaso S; Barattin M; Jarva H; Meri S; Yliperttula M; Viitala T; Urtti A
    Drug Deliv Transl Res; 2017 Apr; 7(2):228-240. PubMed ID: 27491413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein corona of circulating PEGylated liposomes.
    Palchetti S; Colapicchioni V; Digiacomo L; Caracciolo G; Pozzi D; Capriotti AL; La Barbera G; Laganà A
    Biochim Biophys Acta; 2016 Feb; 1858(2):189-96. PubMed ID: 26607013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the biomolecular corona on the structure of PEGylated liposomes.
    Digiacomo L; Pozzi D; Amenitsch H; Caracciolo G
    Biomater Sci; 2017 Aug; 5(9):1884-1888. PubMed ID: 28676869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size Dependence Unveiling the Adsorption Interaction of High-Density Lipoprotein Particles with PEGylated Gold Nanoparticles in Biomolecular Corona Formation.
    Jang GJ; Jeong JY; Kang J; Cho W; Han SY
    Langmuir; 2021 Aug; 37(32):9755-9763. PubMed ID: 34347501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
    Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
    Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
    Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
    Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
    Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
    Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
    Hamad-Schifferli K
    Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome protein corona characterization as a new approach in nanomedicine.
    Capriotti AL; Cavaliere C; Piovesana S
    Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated liposomal doxorubicin in ovarian cancer.
    Green AE; Rose PG
    Int J Nanomedicine; 2006; 1(3):229-39. PubMed ID: 17717964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties
    Giulimondi F; Vulpis E; Digiacomo L; Giuli MV; Mancusi A; Capriotti AL; Laganà A; Cerrato A; Zenezini Chiozzi R; Nicoletti C; Amenitsch H; Cardarelli F; Masuelli L; Bei R; Screpanti I; Pozzi D; Zingoni A; Checquolo S; Caracciolo G
    ACS Nano; 2022 Feb; 16(2):2088-2100. PubMed ID: 35040637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
    Yang K; Mesquita B; Horvatovich P; Salvati A
    Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of liposomal biomolecular corona upon human plasma incubation: The evolution towards the lipid corona.
    La Barbera G; Capriotti AL; Caracciolo G; Cavaliere C; Cerrato A; Montone CM; Piovesana S; Pozzi D; Quagliarini E; Laganà A
    Talanta; 2020 Mar; 209():120487. PubMed ID: 31892008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas.
    Dai Q; Yan Y; Ang CS; Kempe K; Kamphuis MM; Dodds SJ; Caruso F
    ACS Nano; 2015 Mar; 9(3):2876-85. PubMed ID: 25712076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of protein coronas around soft nanoparticles regardless of the chemical nature of the outer surface: structural features and biological consequences.
    de Castro CE; Panico K; Stangherlin LM; Albuquerque LJC; A S Ribeiro C; da Silva MCC; Jäger E; Giacomelli FC
    J Mater Chem B; 2021 Mar; 9(8):2073-2083. PubMed ID: 33594396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona.
    Caracciolo G
    Nanoscale; 2018 Mar; 10(9):4167-4172. PubMed ID: 29450412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.